Target Group Inc.
Target Group Inc. (CBDY): 16 pipeline candidates · ~29 mo cash runway · 2 clinical trials. Updated within the last hour.
BioSniper Score
3-factor signal · derived from public data
28.5 months
D/E -1.71 · 0% dilution
N/A
16 candidates
N/A
N/A
A transparent, data-derived signal for Target Group Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$926K
Cash
$210K
Quarterly Burn
$94K
Runway
28.5 mo
Revenue
$879K
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (16 candidates)
Showing 10 of 16 candidates. Sign up for full pipeline.
Frequently asked questions
How many drug candidates are in Target Group Inc.'s pipeline?
Target Group Inc. (CBDY) has 16 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Target Group Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Target Group Inc. has approximately 28.5 months of cash runway.
What is Target Group Inc.'s market capitalization?
Target Group Inc.'s market capitalization is approximately $926K.
Who is the CEO of Target Group Inc.?
Mr. Anthony Carlo Zarcone is the chief executive officer of Target Group Inc. (CBDY).
Get the full picture on Target Group Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.